IP Library Granted Patent US 8,722,717
Granted Patent B2
US 8,722,717 · App. 12/859,350 · Granted May 13, 2014

3-triazolylphenyl-substituted sulphide derivatives as acaricides and insecticides

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,722,717
App. No.
12/859,350
Granted
May 13, 2014
Kind
B2
Abstract

The present invention constitutes new 3-triazolylphenyl-substituted sulphide derivatives of the formula (I) in which A 1 , A 2 , B 0 , B 1 , B 2 , B 3 , X, R 1 , R 2 and n are as defined in the description, to their use as acaricides and insecticides for controlling animal pests, and to processes for preparing them.

Claims (141)

1. A 3-Triazolylphenyl-substituted sulphide of formula (I)

wherein:

X is N or C-A 0 , where A 0 is hydrogen, halogen, cyano, alkyl, alkoxy, haloalkyl, haloalkoxy, alkoxyalkyl, alkoxyalkoxy, acyl, haloalkylcarbonyl or NR 3 R 4 , where R 3 and R 4 independently of one another are hydrogen, alkyl, haloalkyl, cyanoalkyl, hydroxyalkyl, alkoxyalkyl, alkylthioalkyl, alkenyl, haloalkenyl, cyanoalkenyl, alkynyl, haloalkynyl, cyanoalkynyl, acyl or alkoxycarbonyl, or R 3 and R 4 , together with the N atom to which they are attached, may form an optionally substituted, saturated or unsaturated, five- to eight-membered ring which is optionally interrupted by heteroatoms,

A 1 is trifluoromethyl if X is N,

or is hydrogen, alkyl, haloalkyl, alkoxyalkyl, acyl, haloalkylcarbonyl, carboxyl or alkoxycarbonyl if X is C-A 0 ,

A 2 is hydrogen,

B 0 is hydrogen, amino, halogen, cyano, nitro, alkyl, haloalkyl, alkylthio, haloalkylthio, alkoxy or haloalkoxy,

B 1 , B 2 and B 3 independently of one another are each hydrogen, halogen, cyano, nitro, alkyl, haloalkyl, cyanoalkyl, hydroxyalkyl, alkoxycarbonylalkyl, alkoxyalkyl, alkenyl, haloalkenyl, cyanoalkenyl, alkynyl, haloalkynyl, cyanoalkynyl, alkoxy, haloalkoxy, cyanoalkoxy, alkoxycarbonylalkoxy, alkoxyalkoxy, alkylthio, haloalkylthio, alkoxyalkylthio, alkylsulphinyl, halo alkylsulphinyl, alkoxyalkylsulphinyl, alkylsulphonyl, haloalkylsulphonyl, alkoxyalkylsulphonyl, acyl, haloalkylcarbonyl, carboxyl, alkoxycarbonyl or NR 3 R 4 , where R 3 and R 4 independently of one another are hydrogen, alkyl, haloalkyl, cyanoalkyl, hydroxyalkyl, alkoxyalkyl, alkylthioalkyl, alkenyl, haloalkenyl, cyanoalkenyl, alkynyl, haloalkynyl, cyanoalkynyl, acyl or alkoxycarbonyl, or R 3 and R 4 , together with the N atom to which they are attached, may form an optionally substituted saturated or unsaturated, five- to eight-membered ring which is optionally interrupted by heteroatoms,

n is the number 0, 1 or 2,

R 1 is hydrogen or alkyl,

R 2 is CHF 2 , CF 2 Cl, CFCl 2 , CH 2 Cl, CHCl 2 , CCl 3 , cyano, (C 2 -C 6 )haloalkyl, or is optionally substituted cycloalkyl or cycloalkenyl each of which is interrupted by one or more heteroatoms, or is substituted cycloalkyl or cycloalkenyl, and, if R 1 is not hydrogen, R 2 may additionally be CF 3 .

2. The 3-Triazolylphenyl-substituted sulphide according to claim 1 , where

X is N or C-A 0 , where A 0 is hydrogen, halogen, cyano, (C 1 -C 6 )alkyl, (C 1 -C 6 )alkoxy, (C 1 -C 6 )haloalkyl, (C 1 -C 6 )haloalkoxy, (C 1 -C 6 )alkoxy-(C 1 -C 6 )alkyl, (C 1 -C 6 )alkoxy-(C 1 -C 6 )alkoxy, (C 1 -C 7 )acyl, (C 2 -C 5 )haloalkylcarbonyl or NR 3 R 4 where R 3 and R 4 independently of one another are hydrogen, (C 1 -C 6 )alkyl, (C 1 -C 6 )haloalkyl, (C 1 -C 6 )cyanoalkyl, (C 1 -C 6 )hydroxyalkyl, (C 1 -C 6 )alkoxy-(C 1 -C 6 )alkyl, (C 1 -C 6 )alkylthio-(C 1 -C 6 )alkyl, (C 2 -C 6 )alkenyl, (C 2 -C 6 )haloalkenyl, (C 2 -C 6 )cyanoalkenyl, (C 2 -C 6 )alkynyl, (C 2 -C 6 )haloalkynyl, (C 2 -C 6 )cyanoalkynyl, (C 1 -C 7 )acyl, (C 2 -C 7 )alkoxycarbonyl, or R 3 and R 4 , together with the N atom to which they are attached, may form an optionally (C 1 -C 4 )alkyl-, (C 1 -C 4 )alkoxy- and/or (C 1 -C 4 )haloalkyl-substituted, saturated or unsaturated, five- or six-membered ring which is optionally interrupted by heteroatoms,

A 1 is trifluoromethyl if X is N,

or is hydrogen, (C 1 -C 6 )alkyl, (C 1 -C 6 )haloalkyl, (C 1 -C 3 )alkoxy-(C 1 -C 6 )alkyl, (C 1 -C 7 )acyl, (C 2 -C 5 )haloalkylcarbonyl, carboxyl or (C 2 -C 7 )alkoxycarbonyl if X is C-A 0 ,

B 0 is hydrogen, amino, halogen, cyano, nitro, (C 1 -C 6 )alkyl, (C 1 -C 6 )haloalkyl, (C 1 -C 6 )alkylthio, (C 1 -C 6 )haloalkylthio, (C 1 -C 6 )alkoxy, (C 1 -C 6 )haloalkoxy,

B 1 , B 2 and B 3 independently of one another are each hydrogen, halogen, cyano, nitro, (C 1 -C 6 )alkyl, (C 1 -C 6 )haloalkyl, (C 1 -C 6 )cyanoalkyl, (C 1 -C 6 )hydroxyalkyl, (C 2 -C 7 )alkoxycarbonyl-(C 1 -C 6 )alkyl, (C 1 -C 6 )alkoxy-(C 1 -C 6 )alkyl, (C 2 -C 6 )alkenyl, (C 2 -C 6 )haloalkenyl (C 2 -C 6 )cyanoalkenyl, (C 2 -C 6 )alkynyl, (C 2 -C 6 )haloalkynyl, (C 2 -C 6 )cyanoalkynyl, (C 1 -C 6 )alkoxy, (C 1 -C 6 )haloalkoxy, (C 1 -C 6 )cyanoalkoxy, (C 2 -C 5 )alkoxycarbonyl-(C 1 -C 6 )alkoxy, (C 1 -C 13 )alkoxy-(C 1 -C 6 )alkoxy, (C 1 -C 6 )alkylthio, (C 1 -C 6 )haloalkylthio, (C 1 -C 3 )alkoxy-(C 1 -C 6 )alkylthio, (C 1 -C 6 )alkylsulphinyl, (C 1 -C 6 )haloalkylsulphinyl, (C 1 -C 3 )alkoxy-(C 1 -C 6 )alkylsulphinyl, (C 1 -C 6 )alkylsulphonyl, (C 1 -C 6 )haloalkylsulphonyl, (C 1 -C 3 )alkoxy-(C 1 -C 6 )alkylsulphonyl, (C 1 -C 7 )acyl, (C 2 -C 5 )haloalkylcarbonyl, carboxyl, (C 2 -C 7 )alkoxycarbonyl or NR 3 R 4 , where R 3 and R 4 independently of one another are hydrogen, (C 1 -C 1 )alkyl, (C 1 -C 6 )haloalkyl, (C 1 -C 6 )cyanoalkyl, (C 1 -C 6 )hydroxyalkyl, (C 1 -C 6 )alkoxy-(C 1 -C 6 )alkyl, (C 1 -C 6 )alkylthio-(C 1 -C 6 )alkyl, (C 2 -C 6 )alkenyl, (C 2 -C 6 )haloalkenyl, (C 2 -C 6 )cyanoalkenyl, (C 2 -C 6 )alkynyl, (C 2 -C 6 )haloalkynyl, (C 2 -C 6 )cyanoalkynyl, (C 1 -C 7 )acyl, (C 1 -C 7 )alkoxycarbonyl, or R 3 and R 4 , together with the N atom to which they are attached, may form an optionally (C 1 -C 4 )alkyl-, (C 1 -C 4 )alkoxy-, (C 1 -C 4 )haloalkyl-substituted saturated or unsaturated, five- or six-membered ring which is optionally interrupted by heteroatoms,

n is the number 0, 1 or 2,

R 1 is hydrogen or (C 1 -C 4 )alkyl,

R 2 is CHF 2 , CF 2 Cl, CFCl 2 , cyano or (C 2 -C 6 )haloalkyl, or is optionally substituted (C 3 -C 8 )cycloalkyl or (C 3 -C 8 )cycloalkenyl each of which is interrupted by one or more heteroatoms, or is substituted (C 3 -C 6 )cycloalkyl or (C 3 -C 6 )cycloalkenyl, and, if R 1 is other than hydrogen, R 2 may additionally be CF 3 .

3. The 3-Triazolylphenyl-substituted sulphide according to claim 1 , where

X is N or C-A 0 , where A 0 is hydrogen, halogen, cyano, (C 1 -C 4 )alkyl, (C 1 -C 4 )alkoxy or (C 1 -C 4 )haloalkyl,

A 1 is trifluoromethyl if X is N,

or is hydrogen, (C 1 -C 4 )alkyl, (C 1 -C 4 )haloalkyl, (C 1 -C 4 )alkoxy-(C 1 -C 4 )alkyl, (C 1 -C 4 )acyl, (C 2 -C 4 )haloalkylcarbonyl, carboxyl or (C 2 -C 4 )alkoxycarbonyl if X is C-A 0 ,

A 2 is hydrogen,

B 0 is hydrogen, amino, halogen, cyano, nitro, (C 1 -C 4 )alkyl, (C 1 -C 4 )haloalkyl, (C 1 -C 4 )alkylhio, (C 1 -C 4 )haloalkylthio, (C 1 -C 4 )alkoxy or (C 1 -C 4 )haloalkoxy, B 1 , B 2 and B 3 independently of one another are hydrogen, halogen, cyano, nitro, (C 1 -C 4 )alkyl, (C 1 -C 4 )haloalkyl, (C 2 -C 4 )alkenyl, (C 1 -C 4 )alkoxy or (C 1 -C 4 )haloalkoxy,

n is the number 0 or 1,

R 1 is hydrogen or (C 1 -C 2 )alkyl,

R 2 is CHF 2 , CF 2 Cl, CFCl 2 , cyano or (C 2 -C 4 )haloalkyl, or is optionally substituted (C 3 -C 6 )cycloalkyl or (C 3 -C 6 )cycloalkenyl each of which is interrupted by one or more heteroatoms, or is substituted (C 3 -C 6 )cycloalkyl, and, if R 1 is not hydrogen, R 2 may additionally be CF 3 .

4. The 3-Triazolylphenyl-substituted sulphide of formula I-A according to claim 1

in which A 1 is trifluoromethyl and

A 2 is hydrogen,

B 0 is hydrogen, amino, halogen, cyano, nitro, alkyl, haloalkyl, alkylthio, haloalkylthio, alkoxy or haloalkoxy,

B 1 , B 2 and B 3 independently of one another are each hydrogen, halogen, cyano, nitro, alkyl, haloalkyl, cyanoalkyl, hydroxyalkyl, alkoxycarbonylalkyl, alkoxyalkyl, alkenyl, haloalkenyl, cyanoalkenyl, alkynyl, haloalkynyl, cyanoalkynyl, alkoxy, haloalkoxy, cyanoalkoxy, alkoxycarbonylalkoxy, alkoxyalkoxy, alkylthio, haloalkylthio, alkoxyalkylthio, alkylsulphinyl, halo alkylsulphinyl, alkoxyalkylsulphinyl, alkylsulphonyl, haloalkylsulphonyl, alkoxyalkylsulphonyl, acyl, haloalkylcarbonyl, carboxyl, alkoxycarbonyl or NR 3 R 4 , where R 3 and R 4 independently of one another are hydrogen, alkyl, haloalkyl, cyanoalkyl, hydroxyalkyl, alkoxyalkyl, alkylthioalkyl, alkenyl, haloalkenyl, cyanoalkenyl, alkynyl, haloalkynyl, cyanoalkynyl, acyl or alkoxycarbonyl, or R 3 and R 4 , together with the N atom to which they are attached, may form an optionally substituted saturated or unsaturated, five- to eight-membered ring which is optionally interrupted by heteroatoms,

n is the number 0, 1 or 2,

R 1 is hydrogen or alkyl,

R 2 is CHF 2 , CF 2 Cl, CFCl 2 , CH 2 Cl, CHCl 2 , CCl 3 , cyano, (C 2 -C 6 )haloalkyl, or is optionally substituted cycloalkyl or cycloalkenyl each of which is interrupted by one or more heteroatoms, or is substituted cycloalkyl or cycloalkenyl, and, if R 1 is not hydrogen, R 2 may additionally be CF 3 .

5. The 3-Triazolylphenyl-substituted sulphide of formula I-B according to claim 1

in which

A 0 is hydrogen, halogen, cyano, alkyl, alkoxy, haloalkyl, haloalkoxy, alkoxyalkyl, alkoxyalkoxy, acyl, haloalkylcarbonyl or NR 3 R 4 , where R 3 and R 4 independently of one another are hydrogen, alkyl, haloalkyl, cyanoalkyl, hydroxyalkyl, alkoxyalkyl, alkylthioalkyl, alkenyl, haloalkenyl, cyanoalkenyl, alkynyl, haloalkynyl, cyanoalkynyl, acyl or alkoxycarbonyl, or R 3 and R 4 , together with the N atom to which they are attached, may form an optionally substituted, saturated or unsaturated, five- to eight-membered ring which is optionally interrupted by heteroatoms,

A 1 is hydrogen, alkyl, haloalkyl, alkoxyalkyl, acyl, haloalkylcarbonyl, carboxyl or alkoxycarbonyl and

A 2 is hydrogen,

B 0 is hydrogen, amino, halogen, cyano, nitro, alkyl, haloalkyl, alkylthio, haloalkylthio, alkoxy or haloalkoxy,

B 1 , B 2 and B 3 independently of one another are each hydrogen, halogen, cyano, nitro, alkyl, haloalkyl, cyanoalkyl, hydroxyalkyl, alkoxycarbonylalkyl, alkoxyalkyl, alkenyl, haloalkenyl, cyanoalkenyl, alkynyl, haloalkynyl, cyanoalkynyl, alkoxy, haloalkoxy, cyanoalkoxy, alkoxycarbonylalkoxy, alkoxyalkoxy, alkylthio, haloalkylthio, alkoxyalkylthio, alkylsulphinyl, halo alkylsulphinyl, alkoxyalkylsulphinyl, alkylsulphonyl, haloalkylsulphonyl, alkoxyalkylsulphonyl, acyl, haloalkylcarbonyl, carboxyl, alkoxycarbonyl or NR 3 R 4 , where R 3 and R 4 independently of one another are hydrogen, alkyl, haloalkyl, cyanoalkyl, hydroxyalkyl, alkoxyalkyl, alkylthioalkyl, alkenyl, haloalkenyl, cyanoalkenyl, alkynyl, haloalkynyl, cyanoalkynyl, acyl or alkoxycarbonyl, or R 3 and R 4 , together with the N atom to which they are attached, may form an optionally substituted saturated or unsaturated, five- to eight-membered ring which is optionally interrupted by heteroatoms,

n is the number 0, 1 or 2,

R 1 is hydrogen or alkyl,

R 2 is CHF 2 , CF 2 Cl, CFCl 2 , CH 2 Cl, CHCl 2 , CCl 3 , cyano, (C 2 -C 6 )haloalkyl, or is optionally substituted cycloalkyl or cycloalkenyl each of which is interrupted by one or more heteroatoms, or is substituted cycloalkyl or cycloalkenyl, and, if R 1 is not hydrogen, R 2 may additionally be CF 3 .

6. A process for preparing the 3-Triazolylphenyl-substituted sulphide of formula (I-A) according to claim 4 , comprising

(A) (i) reacting an aniline of formula (VII)

with sodium nitrite to provide a diazonium salt; and

(ii) reducing the diazonium salt to give a hydrazine of formula (VI)

(B) reacting the hydrazine of formula (VI) with an ester of formula (VIII)

where A 1a is alkyl,

to give a hydrazide of formula (V)

(C) reacting the hydrazide of formula (V) with formamidine hydrochloride in the presence of a base to give a triazole of formula (IV-A)

(D) sulphochlorinating the triazole of formula (IV-A) to give a sulphonyl chloride of formula (III-A)

(E) reducing the sulphonyl chloride of formula (III-A) to a disulphide of formula (II-A)

(F) reacting the disulphide of formula (II-A) with an electrophile of formula (IX)

where AG is a leaving group,

to give a sulphide of formula (I-Aa)

(G) reacting the sulphide of formula (I-Aa) with an oxidizing agent to give a sulphoxide of formula (I-Ab)

and a sulphone of formula (I-Ac)

7. The process according to claim 6 , wherein the triazole of formula (IV-A) is prepared by reacting a boronic acid of formula (VIII)

with a triazole of formula (IX-A)

and with a copper catalyst.

8. The process according to claim 6 , wherein the triazole of formula (IV-A) is prepared by reacting a hydrazine of formula (VI)

with an amidine of formula (XI) or a salt thereof

to give an amidrazone of formula (X)

reacting the amidrazone of formula (X) with an orthoformate.

9. An active compound composition comprising the at least one 3-Triazolylphenyl-substituted sulphide, according to claim 1 , of formula (I), or formula (I-A), or formula (I-B); and at least one other active insecticidal, acaricidal or nematicidal compound selected from the group consisting of

(1) Acetylcholinesterase (AChE) inhibitors;

(2) GABA-gated chloride channel antagonists;

(3) Sodium channel modulators;

(4) Nicotinergic acetylcholine receptor agonists;

(5) Allosteric acetylcholine receptor modulators;

(6) Chloride channel activators;

(7) Juvenile hormone analogues;

(8) Active compounds with unknown or non-specific mechanisms of action selected from the group consisting of fumigants, chloropicrin, sulphuryl fluoride, borax and tartar emetic;

(9) Selective antifeedants;

(10) Mite growth inhibitors;

(11) Microbial disruptors of the insect gut membrane;

(12) Oxidative phosphorylation inhibitors;

(13) Oxidative phoshorylation decouplers acting by interrupting a H proton gradient;

(14) Nicotinergic acetylcholine receptor antagonists;

(15) Chitin biosynthesis inhibitors, type 0;

(16) Chitin biosynthesis inhibitors, type 1;

(17) Moulting disruptors;

(18) Ecdysone agonists/disruptors;

(19) Octopaminergic agonists;

(20) Complex-III electron transport inhibitors;

(21) Complex-I electron transport inhibitors;

(22) Voltage-dependent sodium channel blockers;

(23) Inhibitors of acetyl-CoA carboxylase;

(24) Complex-IV electron transport inhibitors;

(25) Complex-II electron transport inhibitors;

(26) Ryanodine receptor effectors;

(27) Further active compounds with unknown mechanism of action selected from the group consisting of azadirachtin, amidoflumet, benzoximate, bifenazate, chino-methionat, cryolite, cyflumetofen, dicofol, fluensulfone (5-chloro-2-[(3,4,4-trifluorobut-3-en-1-yl)sulphonyl]-1,3-thiazole), flufenerim, pyridalyl, pyrifluquinazon, products based on Bacillus firmus, 4-{[(6-bromopyrid-3-yl)methyl](2-fluoroethyl)amino}furan-2(5H)-one, 4-{[(6-fluoropyrid-3-yl)methyl](2,2-difluoroethyl)amino}furan-2(5H)-one, 4-{[(2-chloro-1,3-thiazol-5-yl)methyl](2-fluoroethyl)amino}furan-2(5H)-one, 4-{[(6-chloropyrid-3-yl)methyl](2-fluoroethyl)amino}furan-2(5H)-one, 4-{[(6-chloropyrid-3-yl)methyl](2,2-difluoroethyl)amino}furan-2(5H)-one, 4-{[(6-chloro-5-fluoropyrid-3-yl)methyl](methyl)amino}furan-2(5H)-one, 4-{[(5,6-dichloropyrid-3-yl)methyl](2-fluoroethyl)amino}furan-2(5H)-one, 4-{[(6-chloro-5-fluoropyrid-3-yl)methyl](cyclopropyl)amino}furan-2(5H)-one, 4-{[(6-chloropyrid-3-yl)methyl](cyclopropyl)amino}furan-2(5H)-one, 4-{[(6-chloropyrid-3-yl)methyl](methyl)amino}furan-2(5H)-one, [(6-chloropyridin-3-yl)methyl](methyl)oxido-λ 4 -sulphanylidenecyanamide, [1-(6-chloropyridin-3-yl)ethyl](methyl)oxido-λ 4 -sulphanylidenecyanamide and its diastereomers (A) and (B)

[(6-trifluoromethylpyridin-3-yl)methyl](methyl)oxido-λ 4 -sulphanylidenecyanamide, sulfoxaflor,

11-(4-chloro-2,6-dimethylphenyl)-12-hydroxy-1,4-dioxa-9-azadispiro[4.2.4.2]tetradec-11-en-10-one, 3-(4′-fluoro-2,4-dimethylbiphenyl-3-yl)-4-hydroxy-8-oxa-1-azaspiro[4.5]dec-3-en-2-one,

1-[2-fluoro-4-methyl-5-[(2,2,2-trifluoroethyl)sulphinyl]phenyl]-3-(trifluoromethyl)-1H-1,2,4-triazole-5-amine,

[(3S,4aR,12R,12aS,12bS)-3-[(cyclopropylcarbonyl)oxy]-6,12-dihydroxy-4,12b-dimethyl-11-oxo-9-(pyridin-3-yl)-1,3,4,4a,5,6,6a,12,12a,12b-decahydro-2H,11H-benzo[f]pyrano[4,3-b]chromen-4-yl]methyl cyclopropanecarboxylate,

2-cyano-3-(difluoromethoxy)-N,N-dimethylbenzenesulphonamide,

2-cyano-3-(difluoromethoxy)-N-methylbenzenesulphonamide, 2-cyano-3-(difluoromethoxy)-N-ethylbenzenesulphonamide, 4-(difluoromethoxy)-N-ethyl-N-methyl-1,2-benzothiazole-3-amine 1,1-dioxide and

N-[1-(2,3-dimethylphenyl)-2-(3,5-dimethylphenyl)ethyl]-4,5-dihydro-1,3-thiazole-2-amine,

and/or at least one further active fungicidal compound selected from the group consisting of

(28) Ergosterol biosynthesis inhibitors;

(29) Respiration inhibitors;

(30) Respiration inhibitors on complex III of a respiratory chain;

(31) Mitosis and cell division inhibitors;

(32) Compounds with multi-site activity;

(33) Resistance inductors;

(34) Amino acid and protein biosynthesis inhibitors;

(35) ATP production inhibitors;

(36) Cell wall synthesis inhibitors;

(37) Lipid and membrane synthesis inhibitors;

(38) Melanin biosynthesis inhibitors;

(39) Nucleic acid synthesis inhibitors;

(40) Signal transduction inhibitors;

(41) Decouplers;

(42) Further compounds selected from the group consising of benthiazole, bethoxazin, capsimycin, carvone, chinomethionat, chlazafenon, cufraneb, cyflufenamid, cymoxanil, cyprosulfamide, dazomet, debacarb, dichlorophen, diclomezine, difenzoquat, difenzoquat methylsulphate, diphenylamine, ecomat, fenpyrazamine, flumetover, fluoromid, flusulfamide, flutianil, fosetyl-aluminium, fosetyl-calcium, fosetyl-sodium, hexachlorobenzene, irumamycin, methasulphocarb, methyl isothiocyanate, metrafenone, mildiomycin, natamycin, nickel dimethyldithiocarbamate, nitrothal-isopropyl, octhilinone, oxamocarb, oxyfenthiin, pentachlorophenol and a salt thereof, phenothrin, phosphoric acid and a salt thereof, propamocarb-fosetylate, propanosine-sodium, proquinazid, pyrroInitrin, tebufloquin, tecloftalam, tolnifanid, triazoxide, trichlamide, zarilamide, 1-(4-{4-[(5R)-5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone, 1-(4-{4-[(5S)-5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone, 1-(4-{4-[5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone, 1-(4-methoxyphenoxy)-3,3-dimethylbutan-2-yl 1H-imidazole-1-carboxylate, 2,3,5,6-tetrachloro-4-(methylsulphonyl)pyridine, 2,3-dibutyl-6-chlorothieno[2,3-d]pyrimidin-4(3H)-one, 2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]-1-(4-{4-[(5R)-5-phenyl-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)ethanone, 2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]-1-(4-{4-[(5S)-5-phenyl-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)ethanone, 2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]-1-{4-[4-(5-phenyl-4,5-dihydro-1,2-oxazol-3-yl)-1,3-thiazol-2-yl]piperidin-1-yl}ethanone, 2-butoxy-6-iodo-3-propyl-4H-chromen-4-one, 2-chloro-5-[2-chloro-1-(2,6-difluoro-4-methoxyphenyl)-4-methyl-1H-imidazol-5-yl]pyridine, 2-phenylphenol and its salts, 3,4,5-trichloropyridine-2,6-dicarbonitrile, 3-[5-(4-chlorophenyl)-2,3-dimethyl-1,2-oxazolidin-3-yl]pyridine, 3-chloro-5-(4-chlorophenyl)-4-(2,6-difluorophenyl)-6-methylpyridazine, 4-(4-chlorophenyl)-5-(2,6-difluorophenyl)-3,6-dimethylpyridazine, 5-amino-1,3,4-thiadiazole-2-thiol, 5-chloro-N′-phenyl-N′-(prop-2-yn-1-yl)thiophene-2-sulphonohydrazide, 5-methyl-6-octyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine, ethyl (2Z)-3-amino-2-cyano-3-phenylprop-2-enoate, N-(4-chlorobenzyl)-3-[3-methoxy-4-(prop-2-yn-1-yloxy)phenyl]propanamide, N-[(4-chlorophenyl)cyano)methyl]-3-[3-methoxy-4-(prop-2-yn-1-yloxy)phenyl]propanamide, N-[(5-bromo-3-chloropyridin-2-yl)methyl]-2,4-dichloropyridine-3-carboxamide, N-[1-(5-bromo-3-chloropyridin-2-yl)ethyl]-2,4-dichloropyridine-3-carboxamide, N-[1-(5-bromo-3-chloropyridin-2-yl)ethyl]-2-fluoro-4-iodopyridine-3-carboxamide, N-{(E)-[(cyclopropylmethoxy)imino][6-(difluoromethoxy)-2,3-difluorophenyl]methyl}-2-phenylacetamide, N-{(Z)-[(cyclopropylmethoxy)imino][6-(difluoromethoxy)-2,3-difluorophenyl]methyl}-2-phenylacetamide, N-methyl-2-(1-{[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-1,3-thiazole-4-carboxamide, N-methyl-2-(1-{[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-N-[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]-1,3-thiazole-4-carboxamide, N-methyl-2-(1-{[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]-1,3-thiazole-4-carboxamide, pentyl {6-[({[(1-methyl-1H-tetrazol-5-yl)(phenyl)methylidene]amino}oxy)methyl]pyridin-2-yl}carbamate, phenazine-1-carboxylic acid, quinoline-8-ol, quinoline-8-ol sulphate, 1-methyl-3-(trifluoromethyl)-N-[2′-(trifluoromethyl)biphenyl-2-yl]-1H-pyrazole-4-carboxamide, N-(4′-chlorobiphenyl-2-yl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide, N-(2′,4′-dichlorobiphenyl-2-yl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide, 3-(difluoromethyl)-1-methyl-N-[4′-(trifluoromethyl)biphenyl-2-yl]-1H-pyrazole-4-carboxamide, N-(2′,5′-difluorobiphenyl-2-yl)-1-methyl-3-(trifluoromethyl)-1H-pyrazole-4-carboxamide, 3-(difluoromethyl)-1-methyl-N-[4′-(prop-1-yn-1-yl)biphenyl-2-yl]-1H-pyrazole-4-carboxamide, 5-fluoro-1,3-dimethyl-N-[4′-(prop-1-yn-1-yl)biphenyl-2-yl]-1H-pyrazole-4-carboxamide, 2-chloro-N-[4′-(prop-1-yn-1-yl)biphenyl-2-yl]pyridine-3-carboxamide, 3-(difluoromethyl)-N-[4′-(3,3-dimethylbut-1-yn-1-yl)biphenyl-2-yl]-1-methyl-1H-pyrazole-4-carboxamide, N-[4′-(3,3-dimethylbut-1-yn-1-yl)biphenyl-2-yl]-5-fluoro-1,3-dimethyl-1H-pyrazole-4-carboxamide, 3-(difluoromethyl)-N-(4′-ethynylbiphenyl-2-yl)-1-methyl-1H-pyrazole-4-carboxamide, N-(4′-ethynylbiphenyl-2-yl)-5-fluoro-1,3-dimethyl-1H-pyrazole-4-carboxamide, 2-chloro-N-(4′-ethynylbiphenyl-2-yl)pyridine-3-carboxamide, 2-chloro-N-[4′-(3,3-dimethylbut-1-yn-1-yl)biphenyl-2-yl]pyridine-3-carboxamide, 4-(difluoromethyl)-2-methyl-N-[4′-(trifluoromethyl)biphenyl-2-yl]-1,3-thiazole-5-carboxamide, 5-fluoro-N-[4′-(3-hydroxy-3-methylbut-1-yn-1-yl)biphenyl-2-yl]-1,3-dimethyl-1H-pyrazole-4-carboxamide, 2-chloro-N-[4′-(3-hydroxy-3-methylbut-1-yn-1-yl)biphenyl-2-yl]pyridine-3-carboxamide, 3-(difluoromethyl)-N-[4′-(3-methoxy-3-methylbut-1-yn-1-yl)biphenyl-2-yl]-1-methyl-1H-pyrazole-4-carboxamide, 5-fluoro-N-[4′-(3-methoxy-3-methylbut-1-yn-1-yl)biphenyl-2-yl]-1,3-dimethyl-1H-pyrazole-4-carboxamide, 2-chloro-N-[4′-(3-methoxy-3-methylbut-1-yn-1-yl)biphenyl-2-yl]pyridine-3-carboxamide, (5-bromo-2-methoxy-4-methylpyridin-3-yl)(2,3,4-trimethoxy-6-methylphenyl)methanone and N-[2-(4-{[3-(4-chlorophenyl)prop-2-yn-1-yl]oxy}-3-methoxyphenyl)ethyl]-N2-(methylsulphonyl)valinamide.

10. A composition comprising the at least one 3-Triazolylphenyl-substituted sulphide, according to claim 1 , of formula (I), or formula (I-A), or formula (I-B); and at least one penetrant.

11. A disulphide of formula (II-A)

wherein

A 1 is trifluoromethyl;

B 0 is hydrogen, amino, halogen, cyano, nitro, alkyl, haloalkyl, alkylthio, haloalkylthio, alkoxy or haloalkoxy, and

B 1 , B 2 and B 3 independently of one another are each hydrogen, halogen, cyano, nitro, alkyl, haloalkyl, cyanoalkyl, hydroxyalkyl, alkoxycarbonylalkyl, alkoxyalkyl, alkenyl, haloalkenyl, cyanoalkenyl, alkynyl, haloalkynyl, cyanoalkynyl, alkoxy, haloalkoxy, cyanoalkoxy, alkoxycarbonylalkoxy, alkoxyalkoxy, alkylthio, haloalkylthio, alkoxyalkylthio, alkylsulphinyl, halo alkylsulphinyl, alkoxyalkylsulphinyl, alkylsulphonyl, haloalkylsulphonyl, alkoxyalkylsulphonyl, acyl, haloalkylcarbonyl, carboxyl, alkoxycarbonyl or NR 3 R 4 , where R 3 and R 4 independently of one another are hydrogen, alkyl, haloalkyl, cyanoalkyl, hydroxyalkyl, alkoxyalkyl, alkylthioalkyl, alkenyl, haloalkenyl, cyanoalkenyl, alkynyl, haloalkynyl, cyanoalkynyl, acyl or alkoxycarbonyl, or R 3 and R 4 , together with the N atom to which they are attached, may form an optionally substituted saturated or unsaturated, five- to eight-membered ring which is optionally interrupted by heteroatoms.

12. An agrochemical composition comprising the at least one 3-Triazolylphenyl-substituted sulphide, according to claim 1 , of formula (I), or formula (I-A), or formula (I-B); and extenders and/or surfactants.

13. A process for preparing an agrochemical composition, comprising mixing the at least one 3-Triazolylphenyl-substituted sulphide, according to claim 1 , of formula (I), or formula (I-A), or formula (I-B) with extenders and/or surfactants.

14. A method of controlling animal pests comprising applying the mixing the at least one 3-Triazolylphenyl-substituted sulphide, according to claim 1 , of formula (I), or formula (I-A), or formula (I-B) to animal pests and/or their habitat.

15. A method of controlling animal pests, in the protection of materials and/or in the veterinary sector comprising applying the 3-Triazolylphenyl-substituted sulphide of formula (I) according to claim 1 to animal pests and/or to a habitat of the animal pests.

16. The 3-Triazolylphenyl-substituted sulphide according to claim 1 is a compound of the formula (I-A-1):

17. The process according to claim 6 , wherein A 1 is CF 3 , B 0 is CH 3 , B 1 is H, B 2 is CH 3 , B 3 is H, n is 0, R 1 is H and R 2 is CHF 2 .

18. The process according to claim 7 , wherein A 1 is CF 3 , B 0 is CH 3 , B 1 is H, B 2 is CH 3 and B 3 is H.

19. The process according to claim 8 , wherein A 1 is CF 3 , B 0 is CH 3 , B 1 is H, B 2 is CH 3 and B 3 is H.

20. The active compound composition according to claim 9 , wherein the 3-Triazolylphenyl-substituted sulphide is the compound of the formula (I-A-1).

21. The composition according to claim 10 , wherein the 3-Triazolylphenyl-substituted sulphide is the compound of the Formula (I-A-1).

22. The disulphide of formula (II-A) according to claim 11 , wherein B 0 is CH 3 , B 1 is H, B 2 is CH 3 and B 3 is H.

23. The agrochemical composition according to claim 12 , wherein the at least one 3-Triazolylphenyl-substituted sulphide is the compound of the formula (I-A-1).

24. The process according to claim 13 , wherein the at least one 3-Triazolylphenyl-substituted sulphide is the compound of the formula (I-A-1).

25. The method according to claim 14 , wherein the at least one 3-Triazolylphenyl-substituted sulphide is the compound of the formula (I-A-1).

26. The method according to claim 15 , wherein the 3-Triazolylphenyl-substituted sulphide is the compound of the formula (I-A-1).

Assignments (4)
NUNC PRO TUNC ASSIGNMENT Recorded Jul 4, 2023
From: BAYER INTELLECTUAL PROPERTY GMBH
To: BAYER CROPSCIENCE AKTIENGESELLSCHAFT
Reel/Frame 064198/0823 →
CHANGE OF ADDRESS Recorded Jun 12, 2023
From: BAYER INTELLECTUAL PROPERTY GMBH
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 064021/0344 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 18, 2015
From: BAYER CROPSCIENCE AG
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 035011/0799 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2011
From: ALIG, BERND; ANTONS, STEFAN; FISCHER, REINER; LUI, NORBERT; KOHLER, ADELINE; VOERSTE, ARND; GORGENS, ULRICH
To: BAYER CROPSCIENCE AG
Reel/Frame 026748/0159 →